Search research articles
Contact Us
Filters
Showing results (111-120 of 114) with videos related to
Page
of 12
Sort By:
You have reached the last page of results.
This site can display upto 114 results.
American Journal of Respiratory and Critical Care Medicine
|
July 21, 2001
Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis
G W Hunninghake, M B Zimmerman, D A Schwartz, et al.
Kidney International
|
June 3, 1999
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
R Hirschberg, J Kopple, P Lipsett, et al.
Cultural Diversity & Ethnic Minority Psychology
|
June 16, 2025
Development and validation of the American Indian Multimedia Stimulus (AIMS) set for measuring cultural identity responding
Danielle L Bethel, Nicole R Baughman, Mara J Demuth, et al.
Critical Care Medicine
|
July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group
S M Opal, C J Fisher, J F Dhainaut, et al.
Page
of 12
Search research articles
Search
Showing results (111-120 of 114) with videos related to
Sort By:
Page
of 12
You have reached the last page of results.
This site can display upto 114 results.
American Journal of Respiratory and Critical Care Medicine
|
July 21, 2001
Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis
G W Hunninghake, M B Zimmerman, D A Schwartz, et al.
Kidney International
|
June 3, 1999
Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure
R Hirschberg, J Kopple, P Lipsett, et al.
Cultural Diversity & Ethnic Minority Psychology
|
June 16, 2025
Development and validation of the American Indian Multimedia Stimulus (AIMS) set for measuring cultural identity responding
Danielle L Bethel, Nicole R Baughman, Mara J Demuth, et al.
Critical Care Medicine
|
July 1, 1997
Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group
S M Opal, C J Fisher, J F Dhainaut, et al.
Page
of 12